UK’s £14 billion pharma accord with NHS and pharma industry ushers in new era of healthcare savings
UNITED KINGDOM — In a move set to reshape the National Health Service (NHS), a landmark agreement...
Read More
Tag: NHS
UK government invests £100 million in AI advancements for healthcare and life sciences
UNITED KINGDOM —The UK government has allocated £100 million (US$121.6 million) to expedite the...
Read More
London at risk of 160,000 cases of measles outbreak, health chiefs warn
UNITED KINGDOM —The Health Security Agency of Britain has issued a warning that measles...
Read More
Hospital doctors in England commence 72-hour strike over pay, amplifying concerns for patient care
UNITED KINGDOM — Hospital doctors in England have initiated a new strike lasting 72 hours to...
Read More
NHS unveils state-of-the-art center for cell and gene therapy innovation and production
UNITED KINGDOM — The U.K.’s National Health Service Blood and Transplant (NHSBT),...
Read More
UK’s voluntary reimbursement scheme receives criticism from Big Pharma
UNITED KINGDOM — Following AbbVie and Eli Lilly’s departure from the UK’s voluntary...
Read More
Monkeypox vaccinations to be piloted in lower doses but with equivalent effectiveness
UK- The Monkeypox Vaccine will be made available to eligible patients at three NHS sites as part...
Read More
NHS unveils new test to detect rare eye cancer in unborn babies
UNITED KINGDOM – National Health Service (NHS) England has unveiled a new test for infants in the...
Read More
Orchard Therapeutics secures rare agreement on gene therapy coverage
UNITED KINGDOM – Orchard Therapeutics announced this week that it has reached an agreement with...
Read More
CMA fines firms over US$47m (£35m) for illegal arrangement for NHS drug
UNITED KINGDOM – The Competition and Markets Authority (CMA) has fined companies more than US$47...
Read More
Africa’s health boss seeks to entice expatriate medics to return home
ETHIOPIA – Dr. John Nkengasong, the director of the Africa Centres for Disease Control and...
Read More
Huge blow to Gilead’s and Merck’s HIV strategy as safety concerns mar once-weekly HIV drug combination
USA – Gilead Sciences, Inc. and Merck have temporarily suspended enrollment in a Phase 2...
Read More
LATEST DIGITAL MAGAZINE
